Biomea Fusion Inc. Common Stock (BMEA)
Stock · NASDAQ · Health Care
$1.73as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$1.32
Industry
Biotechnology: Pharmaceutical Preparations
About BMEA
Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It's lead clinical program's drug candidates are COVALENT-111 and COVALENT-112, which has completed Phase II clinical trials of icovamenib for the treatment of Type 1 and Type 2 diabetes; COVALENT-211, which is in Phase II clinical trial of i…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 37
- Website
- biomeafusion.com
Fundamentals
- 1-day range
- $1.26$1.34
- Market cap
- $90.37M
- P/E (trailing)
- —
- P/E (forward)
- -1.40
- EPS (trailing)
- $-0.18
- Dividend yield
- —
- Beta
- -0.30
- Avg. volume
- 833.7K
52-week range
$0.872$2.99
Next earnings: November 3, 2026 · EPS estimate $-0.17confirmed
Forecasts
6 analyst ratings
Buy 86%
Hold 0%
Sell 14%
1-year price forecast
High
$9
+420.2%
Median
$7
+304.6%
Low
$4
+131.2%
Biomea Fusion Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- BMEABiomea Fusion Inc. Common Stock$1.74▲ 3.27%Market cap $90.37MP/E —$0.872$2.99
- NTHINeOnc Technologies Holdings Inc. Common Stock$4.69▲ 1.74%Market cap $90.77MP/E —$3.01$12.99
- FBIOFortress Biotech Inc. Common Stock$2.77▼ 1.07%Market cap $92.02MP/E 0.75$2.18$4.53
- VRCAVerrica Pharmaceuticals Inc. Common Stock$5.54▲ 9.27%Market cap $92.08MP/E —$3.28$9.82
- MAIAMAIA Biotechnology Inc. Common Stock$1.33▼ 3.99%Market cap $86.34MP/E —$0.87$3.19
- ONCYOncolytics Biotech Inc. Common Stock$0.8457▼ 0.51%Market cap $95.55MP/E —$1.39$1.44
- ALDXAldeyra Therapeutics Inc. Common Stock$1.49▼ 3.57%Market cap $95.91MP/E —$1.07$6.18
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BMEA Biomea Fusion Inc. Common Stock | $90.37M | — | $1.74 | ▲ 3.27% | $0.872$2.99 |
| NTHI NeOnc Technologies Holdings Inc. Common Stock | $90.77M | — | $4.69 | ▲ 1.74% | $3.01$12.99 |
| FBIO Fortress Biotech Inc. Common Stock | $92.02M | 0.75 | $2.77 | ▼ 1.07% | $2.18$4.53 |
| VRCA Verrica Pharmaceuticals Inc. Common Stock | $92.08M | — | $5.54 | ▲ 9.27% | $3.28$9.82 |
| MAIA MAIA Biotechnology Inc. Common Stock | $86.34M | — | $1.33 | ▼ 3.99% | $0.87$3.19 |
| ONCY Oncolytics Biotech Inc. Common Stock | $95.55M | — | $0.8457 | ▼ 0.51% | $1.39$1.44 |
| ALDX Aldeyra Therapeutics Inc. Common Stock | $95.91M | — | $1.49 | ▼ 3.57% | $1.07$6.18 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Biomea Fusion Q2 EPS $(0.12) Beats $(0.22) EstimateBenzinga · 8/5/2026
Insider Activity
Insider Actions →Acquired
1.88M
Disposed
0
- Averill Julianne · June 10, 2026 · Grant173.7K
- Ray Sumita · June 10, 2026 · Grant196.3K
- Faust Elizabeth · June 10, 2026 · Grant196.3K
- Eric Aguiar · June 10, 2026 · Grant196.3K
- Michael J.M. Hitchcock · April 1, 2026 · Grant667.5K
- Rainer M. Erdtmann · April 1, 2026 · Grant452.5K
Institutional Ownership
March 31, 2026
- Total shares held
- 24.53M
- Total value held
- $37.37M
- Institutional holders
- 61
Top holders this quarter
- Unknown8.81M
- Unknown2.60M
- Unknown2.05M
- Unknown1.31M
- Unknown1.20M
- Unknown903.7K
- Unknown856.7K
- Unknown654.6K
- Unknown641.4K
- Unknown557.0K
See the full, filterable feed with live charts on the MarketWall dashboard.